Last year, researchers in Sweden published a study linking suicide attempts to higher-than-usual levels of quinolinic acid, a neurotransmitter associated with inflammation.
Now, a team of scientists in Australia is using that finding to develop a blood test to measure levels of quinolinic acid in the blood.
Ostensibly, the test would function as a diagnostic tool to help doctors gauge a depressed person's mental state--the higher the levels of the chemical, the more likely a patient is to attempt suicide.
But would a test like that actually help doctors prevent people from killing themselves? Maybe, but knowing that a patient may be prone to attempting suicide is not the same thing as preventing it from happening.
Arguably, the test will be more useful as a research tool than a diagnostic one--scientists could use it to probe the relationship between the body's immune system and depression, and to further investigate the role of quinolinic acid in brain diseases like Alzheimer's disease, autism and schizophrenia.
Five amazing, clean technologies that will set us free, in this month's energy-focused issue. Also: how to build a better bomb detector, the robotic toys that are raising your children, a human catapult, the world's smallest arcade, and much more.


Online Content Director: Suzanne LaBarre | Email
Senior Editor: Paul Adams | Email
Associate Editor: Dan Nosowitz | Email
Assistant Editor: Colin Lecher | Email
Assistant Editor: Rose Pastore | Email
Contributing Writers:
Rebecca Boyle | Email
Kelsey D. Atherton | Email
Francie Diep | Email
Shaunacy Ferro | Email
"Gattaca"
but seriously it will emprove treatment for patients alredy in the medical database ^^
---
No facts, No response...
Has potential for sure, my only concern is its a matter of time before some pharma company patents an anti-suicide drug.....Side effects may include suicide.